{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:26:47Z","timestamp":1761182807747,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/s10156-004-0361-z","type":"journal-article","created":{"date-parts":[[2005,2,23]],"date-time":"2005-02-23T07:36:27Z","timestamp":1109144187000},"page":"14-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of fosfomycin on nedaplatin-induced nephrotoxicity in rats"],"prefix":"10.1016","volume":"11","author":[{"given":"Yuji","family":"Yoshiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Kanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-004-0361-Z_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2165\/00003495-199346030-00003","article-title":"New cisplatin analogues in development: a review","volume":"46","author":"Weiss","year":"1993","journal-title":"Drugs"},{"key":"10.1007\/s10156-004-0361-Z_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s002800050604","article-title":"In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers","volume":"39","author":"Alberts","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1007\/s10156-004-0361-Z_bib0015","first-page":"1383","article-title":"Pharmacokinetics of platinum in cancer patients following intravenous infusion of cisdiammine(glycolato)platinum, 254-S","volume":"14","author":"Ota","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1007\/s10156-004-0361-Z_bib0020","first-page":"393","article-title":"Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin","volume":"15","author":"Fukuda","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1007\/s10156-004-0361-Z_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00183571","article-title":"Antitumor activities of new platinum compounds, DWA2114R NK121 and 254-S, against human leukemia cells sensitive to cisplatin","volume":"9","author":"Kobayashi","year":"1991","journal-title":"Invest New Drugs"},{"key":"10.1007\/s10156-004-0361-Z_bib0030","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/1097-0142(19930501)71:9<2769::AID-CNCR2820710914>3.0.CO;2-M","article-title":"Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer","volume":"71","author":"Hirabayashi","year":"1993","journal-title":"Cancer"},{"key":"10.1007\/s10156-004-0361-Z_bib0035","first-page":"483","article-title":"A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers","volume":"19","author":"Taguchi","year":"1992","journal-title":"Gan To Kagaku Ryoho (Japanese Journal of Cancer and Chemotherapy)"},{"key":"10.1007\/s10156-004-0361-Z_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF02994087","article-title":"Phase II study of (glycolate-O O\u2019) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer","volume":"26","author":"Fukuda","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1007\/s10156-004-0361-Z_bib0045","first-page":"881","article-title":"A pilot study of nedaplatin and etoposide for recurrent gynecological malignancies","volume":"5","author":"Adachi","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1007\/s10156-004-0361-Z_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1211\/0022357991772187","article-title":"Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats","volume":"51","author":"Nakamura","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1007\/s10156-004-0361-Z_bib0055","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1023\/A:1011971019868","article-title":"Effects of fosfomycin and imipenem\/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats","volume":"15","author":"Nakamura","year":"1998","journal-title":"Pharm Res"},{"key":"10.1007\/s10156-004-0361-Z_bib0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1254\/fpj.107.225","article-title":"Nephrotoxicity and drug interaction of vancomycin (2)","volume":"107","author":"Toyoguchi","year":"1996","journal-title":"Folia Pharmacol Jpn"},{"key":"10.1007\/s10156-004-0361-Z_bib0065","first-page":"907","article-title":"Activities of vancomycin and other antibiotic combinations against methicillin-resistant Staphylococcus aureus","volume":"43","author":"Takahashi","year":"1995","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-004-0361-Z_bib0070","first-page":"1","article-title":"Nephrotoxicity of teicoplanin in rats","volume":"53","author":"Yoshiyama","year":"2000","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-004-0361-Z_bib0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1248\/bpb.21.520","article-title":"Protective effect of ceftriaxone against the nephrotoxicity of isepamicin administered once daily in rats","volume":"21","author":"Yoshiyama","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s10156-004-0361-Z_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s101560170020","article-title":"The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats","volume":"7","author":"Yoshiyama","year":"2001","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-004-0361-Z_bib0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1248\/bpb.25.516","article-title":"Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats","volume":"25","author":"Yazaki","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s10156-004-0361-Z_bib0090","first-page":"62","article-title":"Preventive effect of fosfomycin on the renal toxicity of cisplatin","volume":"38","author":"Kurebe","year":"1985","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-004-0361-Z_bib0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archotol.1994.01880350061011","article-title":"In vitro interaction of cisplatin and fosfomycin on squamous cell carcinoma cultures","volume":"120","author":"Olson","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1007\/s10156-004-0361-Z_bib0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00000441-198801000-00003","article-title":"Supplemental fosfomycin and\/or steroids that reduce cisplatin-induced nephrotoxicity","volume":"295","author":"Umeki","year":"1988","journal-title":"Am J Med Sci"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05710199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05710199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-004-0361-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:44:37Z","timestamp":1761158677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X05710199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"alternative-id":["S1341321X05710199"],"URL":"https:\/\/doi.org\/10.1007\/s10156-004-0361-z","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of fosfomycin on nedaplatin-induced nephrotoxicity in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-004-0361-Z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}